hypericum henryi/抗うつ薬

OBJECTIVES: - Compare the change in depression severity in cancer patients with mild to moderate depression treated with sertraline vs Hypericum perforatum. - Compare the severity of somnolence, nausea, and insomnia in patients treated with these regimens. - Compare the impact of these regimens on

Extract of St. John's wort (SJW: Hypericum perforatum) has gained widespread popularity as an over-the-counter, natural antidepressant. Until recently, SJW was thought to be well tolerated and relatively safe. Within the past year, adverse metabolic interactions have been reported between SJW and

This trial will determine the acute antidepressant efficacy of a standardized extract of hypericum (St. John's Wort) for the treatment of major depressive disorder. For this trial, the primary efficacy analysis will be evaluated at 8 weeks. For observational purposes, a 4-month double blind

Extracts of hypericum perforatum (St. John's wort) have become increasingly popular for the treatment of mood disorders. Hypericum extracts have been approved in Germany for the treatment of mild to moderate depression and are now available in standardized preparations. In the United States,